Numan Raises $60M to Expand Digital Health Platform Beyond Men's Health

Digital men's health platform Numan has closed a $60 million funding round, marking a significant milestone in the company's evolution toward comprehensive digital healthcare services. The financing represents an extension of the company's Series B round and comprises $30 million in equity investment led by Big Pi Ventures, alongside participation from Endeavor Catalyst, White Star Capital, and Novator Partners. The round also includes $27 million in growth capital from HSBC.

Currently operating as a digital subscription service focused on men's health concerns, Numan addresses a range of conditions including hair and weight loss, sexual health issues, and general wellness through supplements and diagnostics. The platform leverages artificial intelligence for symptom checking and provides users with online access to medical professionals, prescription medications, at-home blood testing kits, health coaching services, and direct-to-consumer health products.

The fresh capital injection will fund Numan's strategic expansion into the female health market, representing a significant broadening of its addressable market. Additionally, the company plans to enhance its screening and preventive care programs, positioning itself as a more comprehensive digital health solution provider beyond its current focus on treatment-oriented services.

"We started 2025 in a very strong position, one that allowed us to be genuinely choiceful about our next move," Sokratis Papafloratos, CEO of Numan, said in a statement. "Over the past 18 months we've seen an explosion in demand, our patients have shown incredible engagement and achieved life-changing outcomes. This interest fuelled our growth and success in both reaching and maintaining profitability. That is why we believe now is the time to invest in scaling what works and innovating for the future of healthcare."

The company's fundraising history demonstrates consistent investor confidence, with previous rounds including $20 million in growth debt from Kreos Capital in 2022 and a $38 million raise in 2021. That earlier funding enabled strategic moves such as the acquisition of Stockholm-based medtech firm Vi Health, which brought advanced e-consultation tools, collaborative communication features, and workflow automation capabilities to Numan's platform.

This latest funding round positions Numan to capitalize on the growing demand for accessible, technology-driven healthcare solutions while maintaining its profitable growth trajectory. The expansion into female health represents a natural evolution for the platform, potentially doubling its addressable market while leveraging its existing technological infrastructure and clinical expertise.

Click here for the original news story.